Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Rad Laboratories Inc (NYSE:BIOB)

187.45
Delayed Data
As of Jan 18
 0.00 / 0.00%
Today’s Change
124.50
Today|||52-Week Range
188.00
+2.35%
Year-to-Date
Will 2017 Be Illumina's Best Year Yet?
Jan 13 / MotleyFool.com - Paid Partner Content
Illumina Stock Upgraded: What You Need to Know
Jan 10 / MotleyFool.com - Paid Partner Content
Here's Why Illumina Is Soaring Today
Jan 10 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close187.45
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)635
Market cap$960.1M
Dividend yield--
Data as of 01/18/2017

Growth & Valuation

Earnings growth (last year)+26.23%
Earnings growth (this year)-28.31%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-7.15%
P/E ratio56.3
Price/Sales2.02
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
AXDXAccelerate Diagnosti...0.000.00%
PACBPacific Biosciences ...-0.09-1.98%
HBIOHarvard Bioscience I...0.000.00%
TBIOTransgenomic Inc0.000.00%
Data as of 9:43am ET, 01/20/2017

Financials

Next reporting dateFebruary 24, 2017
EPS forecast (this quarter)$1.11
Annual revenue (last year)$2.0B
Annual profit (last year)$113.1M
Net profit margin5.60%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Norman D. Schwartz
Chief Operating Officer &
Executive Vice President
John Goetz
Corporate headquarters
Hercules, California

Forecasts

Chart unavailable

Search for Jobs